Related Experiment Video

Updated: Jul 1, 2026

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
08:00

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity

Published on: July 10, 2019

Targeting protein kinase B/Akt signaling with vanadium compounds for cardioprotection

Md Shenuarin Bhuiyan1, Norifumi Shioda, Kohji Fukunaga

  • 1Graduate School of Pharmaceutical Sciences, Department of Pharmacology, Tohoku University, Aramaki-Aoba Aoba-ku, Sendai 980-8578, Japan.

Expert Opinion on Therapeutic Targets
|September 11, 2008
PubMed
Abstract

Insights

Vanadium compounds, like bis(1-oxy-2-pyridinethiolato) oxovanadium (IV), protect the heart by activating Akt signaling. This pathway enhances survival and recovery after heart attacks, offering potential as a cardioprotective drug.

Area of Science:

  • Biochemistry
  • Cardiovascular Science
  • Pharmacology

Background:

  • Akt is a key signaling molecule regulating cell growth, survival, and metabolism.
  • Akt activation is a potential therapeutic strategy for increasing cardiomyocyte survival post-ischemia.

Purpose of the Study:

  • To investigate the cardioprotective effects of vanadium compounds via Akt signaling.
  • To evaluate bis(1-oxy-2-pyridinethiolato) oxovanadium (IV) for myocardial infarction and cardiac functional recovery.

Main Methods:

  • Investigated vanadium compounds' mechanism of action on Akt signaling.
  • Assessed the cytoprotective and functional recovery effects of a specific vanadium compound in myocardial infarction models.

Main Results:

  • Vanadium compounds activate Akt signaling by inhibiting protein tyrosine phosphatases.
  • Bis(1-oxy-2-pyridinethiolato) oxovanadium (IV) demonstrated potent cytoprotective effects and improved cardiac function post-myocardial infarction.
  • Cardioprotection and functional recovery were linked to Akt signaling pathway activation.

Conclusions:

  • Vanadium compounds' ability to activate Akt signaling is crucial for modulating cardiovascular functions.
  • These compounds show promise as cardioprotective agents, particularly for patients undergoing reperfusion therapy after myocardial infarction.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...